We serve Chemical Name:Sodium 1-pyrenesulfonate CAS:59323-54-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Sodium 1-pyrenesulfonate
CAS.NO:59323-54-5
Synonyms:1-pyrenesulfonic acid sodium salt;pyrenesulfonic acid,sodium salt;Sodium 1-pyrenesulfonate;sodium pyrene-1-sulphonate;sodium pyrene-1-sulfonate;1-Pyrenesulfonic acid, sodium salt (1:1)
Molecular Formula:C16H9NaO3S
Molecular Weight:304.296
HS Code:2904100000
Physical and Chemical Properties:
Melting point:233-236ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:65.58000
Exact Mass:304.016998
LogP:4.56890
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 1-pyrenesulfonic acid sodium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Pyrenesulfonic acid, sodium salt (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Sodium 1-pyrenesulfonate Use and application,sodium pyrene-1-sulfonate technical grade,usp/ep/jp grade.
Related News: By integrating biocatalysis into ongoing and newly launched projects, Wavelength Pharmaceuticals has shown that it is possible to reduce overall costs by as much as 30%. (S)-2-hydroxy-3-(methoxycarbonyl)propionamide manufacturers This scheme also stipulates minimum domestic value addition in different target segments. Fermentation based products should have at least 90% and chemical synthesis based products should have at least 70% domestic content to qualify for the benefits. 4-Pyridazinol, 6-chloro-3-[2-(1-phenylcyclopropyl)phenoxy]- suppliers An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product. N,N’-bis(2-((hydroxyethyl)amino)ethyl)-1,4:5,8-naphthalenetetracarboximide vendor & factory Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available.,As for argenx’s efgartigimod, that drug hasn’t scored an FDA nod yet and its eventual cost-effectiveness will depend on its price.
